HK1048440A1 - 治療體重增加的方法 - Google Patents

治療體重增加的方法

Info

Publication number
HK1048440A1
HK1048440A1 HK02109422.7A HK02109422A HK1048440A1 HK 1048440 A1 HK1048440 A1 HK 1048440A1 HK 02109422 A HK02109422 A HK 02109422A HK 1048440 A1 HK1048440 A1 HK 1048440A1
Authority
HK
Hong Kong
Prior art keywords
weight gain
treating weight
treating
gain
weight
Prior art date
Application number
HK02109422.7A
Other languages
English (en)
Chinese (zh)
Inventor
J Reinstein Michael
Martin Jones Andrew
Original Assignee
阿斯特拉曾尼卡有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9911499.3A external-priority patent/GB9911499D0/en
Priority claimed from GB0002762A external-priority patent/GB0002762D0/en
Application filed by 阿斯特拉曾尼卡有限公司 filed Critical 阿斯特拉曾尼卡有限公司
Publication of HK1048440A1 publication Critical patent/HK1048440A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
HK02109422.7A 1999-05-19 2002-12-30 治療體重增加的方法 HK1048440A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9911499.3A GB9911499D0 (en) 1999-05-19 1999-05-19 Medicament
GB0002762A GB0002762D0 (en) 2000-02-08 2000-02-08 Method of treatment
PCT/GB2000/001875 WO2000071106A2 (fr) 1999-05-19 2000-05-16 Methode de traitement

Publications (1)

Publication Number Publication Date
HK1048440A1 true HK1048440A1 (zh) 2003-04-04

Family

ID=26243587

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02109422.7A HK1048440A1 (zh) 1999-05-19 2002-12-30 治療體重增加的方法

Country Status (6)

Country Link
EP (1) EP1223939A1 (fr)
JP (1) JP2003500353A (fr)
AU (1) AU4598400A (fr)
CA (1) CA2363784A1 (fr)
HK (1) HK1048440A1 (fr)
WO (1) WO2000071106A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359919B1 (fr) * 2001-02-06 2007-04-25 AstraZeneca AB Utilisation de la quetiapine pour le traitement de la dependance a la cocaine
EP1795199A3 (fr) * 2001-02-06 2007-07-25 AstraZeneca AB Quétiapine pour traiter la dépendance à une substance ou l'abus d'une substance
ATE406166T1 (de) * 2001-07-23 2008-09-15 Corcept Therapeutics Inc Verfahren zur prävention von gewichtszunahme infolge von antipsychotika
BRPI0506807A (pt) * 2004-04-22 2007-05-29 Mor Research Applic Ltd método de gerenciamento de consumo de alimento e composição farmacológica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604465D0 (en) * 1996-03-01 1996-05-01 Smithkline Beecham Plc Novel method
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
WO2000054764A2 (fr) * 1999-03-18 2000-09-21 Children's Hospital Research Foundation Traitement de la boulimie et de troubles de l'alimentation associes par administration d'antipsychotiques atypiques

Also Published As

Publication number Publication date
EP1223939A1 (fr) 2002-07-24
JP2003500353A (ja) 2003-01-07
AU4598400A (en) 2000-12-12
CA2363784A1 (fr) 2000-11-30
WO2000071106A3 (fr) 2002-05-10
WO2000071106A2 (fr) 2000-11-30

Similar Documents

Publication Publication Date Title
PL352993A1 (en) Methods of treating and/or suppressing weight gain
GB2351661B (en) Novel method of treatment
IL144172A0 (en) Method of treating sexual disturbances
IL145875A0 (en) Novel method of treatment
PL342076A1 (en) Method of treating surfaces
EP1197498A4 (fr) Proc d de traitement de polym res
HK1048440A1 (zh) 治療體重增加的方法
AU3009401A (en) Method of treating fabrics
GB9930688D0 (en) Novel method of treatment
PL341752A1 (en) Method of obtaining aryloamino hydroxyantraquinones
GB9812941D0 (en) Method of treatment
GB9930696D0 (en) Novel method of treatment
GB9903950D0 (en) Method of treatment
TJ99000556A (en) Method of treatment of nevrodermite
GB9915597D0 (en) Method of treatment
GB0021144D0 (en) Method of treating nonpoultry meats
PL333334A1 (en) Method of obtaining silylethenes
GB9822681D0 (en) Method of treatment
GB0122638D0 (en) Novel method of treatment
GB9930692D0 (en) Novel method of treatment
GB9930689D0 (en) Novel method of treatment
GB9930690D0 (en) Novel method of treatment
PL334696A1 (en) Method of treating wastes
PL336550A1 (en) Method of decoposing 2-chloroethenylchloroarsazine
AU7923600A (en) Method of treating fabric